CRN-02481

N/A

Report date: 2022/05/31 17:24:15
NME

Base Information

Drug NameCRN-02481
Drug Alias NameCRN-02481
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 5 agonists
TargetsSomatostatin receptor 5
Therapy Area/IndicationsCongenital Hyperinsulinism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrinetics Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCongenital Hyperinsulinism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A